{{Rsnum
|rsid=9364554
|Gene=SLC22A3
|Chromosome=6
|position=160412632
|Orientation=plus
|GMAF=0.219
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLC22A3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 51.3 | 42.5 | 6.2
| HCB | 45.6 | 44.1 | 10.3
| JPT | 46.4 | 40.2 | 13.4
| YRI | 98.6 | 1.4 | 0.0
| ASW | 91.2 | 7.0 | 1.8
| CHB | 45.6 | 44.1 | 10.3
| CHD | 41.7 | 45.4 | 13.0
| GIH | 52.5 | 41.6 | 5.9
| LWK | 94.5 | 5.5 | 0.0
| MEX | 70.2 | 26.3 | 3.5
| MKK | 87.1 | 12.9 | 0.0
| TSI | 59.4 | 34.7 | 5.9
| HapMapRevision=28
}}[http://cancergenetics.wordpress.com/2008/02/15/prostate-cancer-oldnew-snps-and-decodeprca/ cancer-genetics] these snps influence genetic risk for [[prostate cancer]]
*the [[haplotype]] [[rs6983267]] [[rs1016343]] [[rs4242384]] 
*[[rs7501939]] 
*[[rs1859962]]
*[[rs2660753]]
*[[rs9364554]]
*[[rs6465657]]
*[[rs10993994]]
*[[rs7931342]]
*[[rs2735839]]
*[[rs5945619]]
*[[rs10993994]]

{{GWAS Summary
|SNP=rs9364554
|PubMedID=18264097
|Condition=Prostate cancer
|Gene=SLC22A3
|Risk Allele=T
|pValue=6.00E-010
|OR=1.17
|95CI=1.08-1.26
}}
{{PMID Auto
|PMID=19336566
|Title=Replication of the 10q11 and Xp11 Prostate Cancer Risk Variants: Results from a Utah Pedigree-Based Study.
|OA=1
}}

{{PharmGKB
|RSID=rs9364554
|Name_s=
|Gene_s=SLC22A3
|Feature=
|Evidence=PubMed ID:18264097; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS Results: Multiple newly identified loci associated with prostate cancer susceptibility (Initial Sample Size: 1,854 cases, 1,894 controls; Replication Sample Size: 3,268 cases, 3,366 controls; Risk Allele: rs9364554-T).
|Drugs=
|Drug Classes=
|Diseases=Prostatic Neoplasms
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356749
}}

{{PMID Auto
|PMID=20651075
|Title=Prostate Cancer Susceptibility Variants Confer Increased Risk of Disease Progression
|OA=1
}}

{{PMID Auto
|PMID=21820706
|Title=Prostate Cancer Risk Alleles and Their Associations With Other Malignancies
|OA=1
}}

{{PMID Auto
|PMID=18708398
|Title=Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium.
|OA=1
}}

{{PMID Auto
|PMID=18794092
|Title=Association of prostate cancer risk variants with clinicopathologic characteristics of the disease.
|OA=1
}}

{{PMID Auto
|PMID=18974127
|Title=Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer.
|OA=1
}}

{{PMID Auto
|PMID=19074884
|Title=Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=19104501
|Title=Prostate cancer genomics: towards a new understanding.
|OA=1
}}

{{PMID Auto
|PMID=19318432
|Title=Generalizability of associations from prostate cancer genome-wide association studies in multiple populations.
|OA=1
}}

{{PMID Auto
|PMID=19366831
|Title=Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.
|OA=1
}}

{{PMID Auto
|PMID=19434657
|Title=Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
|OA=1
}}

{{PMID Auto
|PMID=19549807
|Title=Prostate cancer risk associated loci in African Americans.
|OA=1
}}

{{PMID Auto
|PMID=19639606
|Title=Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases.
|OA=1
}}

{{PMID Auto
|PMID=20039378
|Title=Estimation of genotype relative risks from pedigree data by retrospective likelihoods.
|OA=1
}}

{{PMID Auto
|PMID=20569440
|Title=Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer.
|OA=1
}}

{{PMID Auto
|PMID=20690139
|Title=Meta-analysis of genome-wide and replication association studies on prostate cancer.
}}

{{PMID Auto
|PMID=21390317
|Title=Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
|OA=1
}}

{{PMID Auto
|PMID=21520160
|Title=Prostate cancer risk variants are not associated with disease progression.
}}

{{PMID Auto
|PMID=21538423
|Title=Early onset prostate cancer has a significant genetic component.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9364554
|overall_frequency_n=24
|overall_frequency_d=128
|overall_frequency=0.1875
|n_genomes=16
|n_genomes_annotated=0
|n_haplomes=20
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}